Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

CGS-28106 for hypertension and congestive heart failure

Sep. 6, 1996

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

New angiotensin II antagonists from Kotobuki

Sep. 6, 1996

alpha1-Adrenoceptor blockers with advantages over prazosin

Sep. 6, 1996

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

CPC-111 clinical trial results disclosed

Aug. 30, 1996

MHC-II and related molecules for treating septic shock

Aug. 30, 1996

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

BTG and the New England Medical Center sign marketing agreement

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...